Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124617102 | 12461710 | 2 | F | 20140307 | 20160922 | 20160613 | 20160925 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-20574448 | BRISTOL MYERS SQUIBB | 71.40 | YR | M | Y | 120.10000 | KG | 20160925 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124617102 | 12461710 | 1 | PS | ELOTUZUMAB. | ELOTUZUMAB | 1 | Intravenous (not otherwise specified) | 1144 MG, QD | Y | 761035 | 1144 | MG | POWDER FOR SOLUTION FOR INFUSION | QD | |||||
| 124617102 | 12461710 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 15JUL13-03MAR14:40MG | Y | 0 | 40 | MG | TABLET | QD | |||||
| 124617102 | 12461710 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 8 MG, UNK | Y | 0 | 8 | MG | SOLUTION FOR INFUSION | ||||||
| 124617102 | 12461710 | 4 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | 15 MG, QD | Y | 0 | 15 | MG | QD | ||||||
| 124617102 | 12461710 | 5 | C | JURNISTA | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 6 | C | PANADOL | ACETAMINOPHEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 8 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 9 | C | COVERSYL /00790702/ | PERINDOPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 10 | C | OSTELIN /00107901/ | 2 | Unknown | UNK | U | 0 | ||||||||||
| 124617102 | 12461710 | 11 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 12 | C | COLOXYL WITH SENNA | DOCUSATESENNOSIDES | 1 | Unknown | U | 0 | ||||||||||
| 124617102 | 12461710 | 13 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 14 | C | INTRAGAM P | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 15 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 16 | C | SLOW-K | POTASSIUM CHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 17 | C | KEFLEX | CEPHALEXIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 18 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124617102 | 12461710 | 19 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | 11MAR2014-17MAR2014 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124617102 | 12461710 | 1 | Plasma cell myeloma |
| 124617102 | 12461710 | 2 | Plasma cell myeloma |
| 124617102 | 12461710 | 3 | Plasma cell myeloma |
| 124617102 | 12461710 | 4 | Plasma cell myeloma |
| 124617102 | 12461710 | 5 | Product used for unknown indication |
| 124617102 | 12461710 | 6 | Product used for unknown indication |
| 124617102 | 12461710 | 7 | Product used for unknown indication |
| 124617102 | 12461710 | 8 | Product used for unknown indication |
| 124617102 | 12461710 | 9 | Product used for unknown indication |
| 124617102 | 12461710 | 10 | Product used for unknown indication |
| 124617102 | 12461710 | 11 | Product used for unknown indication |
| 124617102 | 12461710 | 12 | Product used for unknown indication |
| 124617102 | 12461710 | 13 | Product used for unknown indication |
| 124617102 | 12461710 | 14 | Product used for unknown indication |
| 124617102 | 12461710 | 15 | Product used for unknown indication |
| 124617102 | 12461710 | 16 | Product used for unknown indication |
| 124617102 | 12461710 | 17 | Product used for unknown indication |
| 124617102 | 12461710 | 18 | Product used for unknown indication |
| 124617102 | 12461710 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124617102 | 12461710 | OT |
| 124617102 | 12461710 | HO |
| 124617102 | 12461710 | LT |
| 124617102 | 12461710 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124617102 | 12461710 | Biliary sepsis | |
| 124617102 | 12461710 | Malignant neoplasm progression | |
| 124617102 | 12461710 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124617102 | 12461710 | 1 | 20130715 | 20140224 | 0 | |
| 124617102 | 12461710 | 2 | 20130715 | 20140303 | 0 | |
| 124617102 | 12461710 | 3 | 20130715 | 20140224 | 0 | |
| 124617102 | 12461710 | 4 | 20130715 | 20140307 | 0 | |
| 124617102 | 12461710 | 5 | 20130711 | 20140322 | 0 | |
| 124617102 | 12461710 | 6 | 2000 | 20140326 | 0 | |
| 124617102 | 12461710 | 7 | 2000 | 20140322 | 0 | |
| 124617102 | 12461710 | 8 | 20051130 | 20140322 | 0 | |
| 124617102 | 12461710 | 9 | 2000 | 20140307 | 0 | |
| 124617102 | 12461710 | 10 | 2013 | 20140319 | 0 | |
| 124617102 | 12461710 | 11 | 20130711 | 20140407 | 0 | |
| 124617102 | 12461710 | 13 | 20130711 | 20140323 | 0 | |
| 124617102 | 12461710 | 14 | 20130823 | 20160214 | 0 | |
| 124617102 | 12461710 | 15 | 20130819 | 20160328 | 0 | |
| 124617102 | 12461710 | 16 | 20131008 | 20160312 | 0 | |
| 124617102 | 12461710 | 17 | 20140311 | 20140317 | 0 | |
| 124617102 | 12461710 | 18 | 20130810 | 20130818 | 0 | |
| 124617102 | 12461710 | 19 | 20140307 | 20140308 | 0 |